| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Feb 2025 | 7 Feb 2025 |
| SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and nine months ended December 31 2024 and any other item as may be decided by the Board of Directors. Enclosed - outcome of Board Meeting. (As Per BSE Announcement dated on 12.02.2025) | ||
| Board Meeting | 13 Nov 2024 | 8 Nov 2024 |
| SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 inter alia to consider and approve Unaudited financial results (Standalone and Consolidated) of the Company for the quarter and half year ended September 30. 2024 and any other item as may be decided by the Board of Directors. Outcome of Board meeting (As Per BSE Announcement Dated on: 13/11/2024) | ||
| Board Meeting | 9 Aug 2024 | 6 Aug 2024 |
| SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve 1. Unaudited financial results (Standalone and Consolidated) of the Company for the quarter ended June 30 2024 2. Board report for the year 2023-24 and fixing the date of 18th Annual General Meeting 3. any other item as may be decided by the Board of Directors. Outcome of Board meeting (As Per BSE Announcement Dated on 09.08.2024) | ||
| Board Meeting | 27 May 2024 | 21 May 2024 |
| SMS Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2024 inter alia to consider and approve 1. Audited financial results (Standalone and Consolidated) of the Company for the fourth quarter and year ended March 31 2024. 2. Discuss to recommend dividend for the financial year 2023-24 if any. 3. any other item as may be decided by the Board of Directors. Financial results (Q4/F24) Mr. Mukesh P. Shewalkar is appointed as Senior Management Personnel of the Company, designated as General Manager (R&D head) . Appointment of Cost Auditors & Reappointment of Secretarial Auditor for the year 2024-25. (As Per BSE Announcement Dated on 27/05/2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
